DENV and SARS-CoV-2 and their coexistence in an endemic area
Abstract
The circulation of SARS-CoV-2 in endemic regions of dengue fever and its confluence with DENV has been a reason for study. The objective of this study was to determine the epidemiological characteristics of the simultaneous circulation of both viruses in an endemic region and estimate the prevalence of SARS-CoV-2 in patients with dengue infection. A retrospective search of epidemiological databases of both diseases was performed. The records in both databases were classified as Co-infection and reinfection, non-simultaneous infection, and initial dengue diagnosis. The estimated prevalence of SARS-CoV-2 infection in individuals with dengue was 2%. No significant differences were observed in relation to the frequency of symptoms in patients with co-infection versus those with SARS-CoV-2 infection. SARS-CoV-2 was more frequent in non-simultaneous infections as a first infection followed by dengue acquired during the COVID-19 lockdown. Co-infections with both viruses occur in populations from dengue-endemic regions. Due to the similarity of symptoms during the first days of infection, it is important to study the clinical and epidemiological characteristics to reach an opportune diagnosis.
Downloads
References
Muller DA, Depelsenaire ACI, Young PR. Clinical and laboratory diagnosis of dengue virus infection. J. Infect. Dis. 2017;215(Suppl 2):S89–95.
Leta S, Beyene TJ, De Clercq EM, Amenu K, Kraemer MUG, Revie CW. Global risk mapping for major diseases transmitted by Aedes aegypti and Aedes albopictus. Int. J. Infect. Dis. 2018;67:25–35.
OMS. Organización Mundial de la Salud. 2021 [citado el 14 de abril de 2021]. Coronavirus. Disponible en: https://www.who.int/es/health-topics/coronavirus#tab=tab_1
CDC. Centros para el control y la prevención de enfermedades. 2020 [citado el 21 de septiembre de 2023]. El dengue y el COVID-19. Disponible en: https://www.cdc.gov/dengue/es/is-it-dengue-or-covid.html
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382(8):727–33.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
Simmons CP, Farrar JJ, van Vinh Chau N, Wills B. Dengue. N. Engl. J. Med. 2012;366(15):1423–32.
Verduyn M, Allou N, Gazaille V, Andre M, Desroche T, Jaffar MC, et al. Co-infection of dengue and covid-19: A case report. PLoS Negl. Trop. Dis. 2020;14(8):1–5.
Nacher M, Douine M, Gaillet M, Flamand C, Rousset D, Rousseau C, et al. Simultaneous dengue and COVID-19 epidemics: Difficult days ahead? PLoS Negl. Trop. Dis. 2020;14(8):1–8.
Rosso F, Parra-Lara LG, Agudelo-Rojas OL, Martinez-Ruiz DM. Differentiating Dengue from COVID-19: Comparison of Cases in Colombia. Am. J. Trop. Med. Hyg. 2021;105(3):745–50.
Joubert A, Andry F, Bertolotti A, Accot F, Koumar Y, Legrand F, et al. Distinguishing non severe cases of dengue from covid-19 in the context of co-epidemics: A cohort study in a sars-cov-2 testing center on reunion island. PLoS Negl. Trop. Dis. 2021;15(4):1–13.
Yan G, Lee CK, Lam LTM, Yan B, Chua YX, Lim AYN, et al. Covert COVID-19 and false-positive dengue serology in Singapore. Lancet Infect. Dis. 2020;20(5):536.
Lustig Y, Keler S, Kolodny R, Ben-Tal N, Atias-Varon D, Shlush E, et al. Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses. Clin. Infect. Dis. 2020;2(Xx Xxxx):1–6.
Saavedra-Velasco M, Chiara-Chilet C, Pichardo-Rodriguez R, Grandez-Urbina A, Inga-Berrospi F. [Coinfection between dengue and covid-19: need for approach in endemic zones.]. Rev. Fac. Cien. Med. Univ. Nac. Cordoba. 2020;77(1):52–4.
Dirección General de Epidemiologia. Lineamiento estandarizado para vigilancia epidemiológica y por laboratorio de la enfermedad respiratoria viral. México; 2021 ene.
Dirección General de Epidemiologia. Lineamientos para la vigilancia por laboratorio. Dengue y otras arbovirosis. México; 2021 abr.
Harapan H, Ryan M, Yohan B, Abidin RS, Nainu F, Rakib A, et al. Covid-19 and dengue: Double punches for dengue-endemic countries in Asia. Rev. Med. Virol. 2021;31(2):1–9.
El-Qushayri AE, Kamel AMA, Reda A, Ghozy S. Does dengue and COVID-19 co-infection have worse outcomes? A systematic review of current evidence. Rev. Med. Virol. 2022;32(5):1–7.
Estofolete CF, Machado LF, Zini N, Luckemeyer GD, Moraes MM, dos Santos TMIL, et al. Presentation of fatal stroke due to SARS-CoV-2 and dengue virus coinfection. J. Med. Virol. 2021;93(3):1770–5.
Bicudo N, Bicudo E, Costa JD, Castro JALP, Barra GB. Co-infection of SARS-CoV-2 and dengue virus: a clinical challenge. Brazilian J. Infect. Dis. 2020;24(5):452–4.
Ratnarathon AC, Pongpirul K, Pongpirul WA, Charoenpong L, Prasithsirikul W. Potential dual dengue and SARS-CoV-2 infection in Thailand: A case study. Heliyon. 2020;6(6):5–6.
Agudelo-Rojas OL, Tello-Cajiao ME, Rosso F. Challenges of dengue and coronavirus disease 2019 coinfection: two case reports. J. Med. Case. Rep. 2021;15(1):1–6.
Valdés GJL, Valdés GEM, Solis CU, Sigcho RSF. Revista Cubana de Reumatología. Rev. Cuba. Reumatol. [Internet]. 2020;22(No. extraordinario):e176. Disponible en: https://orcid.org/0000-0003-2453-7833
Mejía-Parra JL, Aguilar-Martinez S, Fernández-Mogollón JL, Luna C, Bonilla-Aldana DK, Rodriguez-Morales AJ, et al. Characteristics of patients coinfected with Severe Acute Respiratory Syndrome Coronavirus 2 and dengue virus, Lambayeque, Peru, May–August 2020: A retrospective analysis. Travel Med. Infect. Dis. 2021;43.
Reyes-Ruiz JM, Campuzano-Vences R, Osuna-Ramos JF, de Jesus-González LA, Pérez-Méndez MJ, González-González C, et al. Case report: Extrapulmonary manifestations of COVID-19 and dengue coinfection. Am. J. Trop. Med. Hyg. 2021;105(2):363–97.
Hinojosa-Velasco A, de Oca PVBM, García-Sosa LE, Mendoza-Durán JG, Pérez-Méndez MJ, Dávila-González E, et al. A case report of newborn infant with severe COVID-19 in Mexico: Detection of SARS-CoV-2 in human breast milk and stool. Int. J. Infect. Dis. 2020; 100:21–4.
Carosella LM, Pryluka D, Maranzana A, Barcan L, Cuini R, Freuler C, et al. Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus. Emerg. Infect. Dis. 2021;27(2).
Hilmy AI, Dey RK, Imad HA, Yoosuf AA, Nazeem A, Latheef AA. Coronavirus disease 2019 and dengue: two case reports. J. Med. Case. Rep. 2021;15(1):1–5.
Kembuan GJ. Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap? IDCases. 2020;22.
Somasetia DH, Malahayati TT, Andriyani FM, Setiabudi D, Nataprawira HM. A fatal course of multiple inflammatory syndrome in children coinfection with dengue. A case report from Indonesia. IDCases. 2020;22.
Schmid MA, González KN, Shah S, Peña J, Mack M, Talarico LB, et al. Influenza and dengue virus co-infection impairs monocyte recruitment to the lung, increases dengue virus titers, and exacerbates pneumonia. Eur. J. Immunol. 2017;47(3):527–39.
Stringari LL, de Souza MN, de Medeiros Junior NF, Goulart JP, Giuberti C, Dietze R, et al. Covert cases of severe acute respiratory syndrome coronavirus 2: An obscure but present danger in regions endemic for Dengue and Chikungunya viruses. PLoS One. 2021;16:1–21.
Lim JT, Dickens BSL, Chew LZX, Choo ELW, Koo JR, Aik J, et al. Impact of SARS-CoV-2 interventions on dengue transmission. PLoS Negl. Trop. Dis. 2020;14(10):1–17.
Barrera-Pérez MA, Pavía-Ruz N MMJ, Torres-Arcila N HHR, Castro-Gamboa F, Geded-Moreno E CRA, Medina-Barreiro A, et al. Control de criaderos de Aedes aegypti con el programa Recicla por tu bienestar en Mérida, México. Salud Publica Mex. 2015;57(3):201–10.
Villegas-Trejo A, Che-Mendoza A, González-Fernández M, Guillermo-May G, González-Bejarano H, Dzul-Manzanilla F, et al. Control enfocado de Aedes aegypti en localidades de alto riesgo de transmisión de dengue en Morelos, México. Salud Publica Mex. 2011;53(2):141–51.
Joob B, Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. J. Am. Acad. Dermatol. 2020;395(10223):10223.
Wilder-Smith A, Tissera H, Ooi EE, Coloma J, Scott TW, Gubler DJ. Preventing dengue epidemics during the COVID-19 pandemic. Am. J. Trop. Med. Hyg. 2020;103(2):570–1.
Saavedra-Velasco M, Chiara-Chilet C, Pichardo-Rodriguez R, Grandez-Urbina A, Inga-Berrospi F. Coinfection between dengue and covid-19: need for approach in endemic zones. Rev. Fac. Cien. Med. Univ. Nac. Cordoba. [Internet]. 2020;77(1):52–4. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/32238260
Wong HYF, Lam HYS, Fong AHT, Leung ST, Chin TWY, Lo CSY, et al. Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19. Radiology. 2020;296(2):E72–8.
Rubin GD, Ryerson CJ, Haramati LB, Sverzellati N, Kanne JP, Raoof S, et al. The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic: A Multinational Consensus Statement From the Fleischner Society. Chest. 2020;158(1):106–16.
Kuo BJ, Lai YK, Tan MLM, Goh XYC. Utility of screening chest radiographs in patients with asymptomatic or minimally symptomatic COVID-19 in Singapore. Radiology. 2021;298(3):E131–40.
Hilmy AI, Dey RK, Imad HA, Yoosuf AA, Nazeem A, Latheef AA. Coronavirus disease 2019 and dengue : two case reports. J. Med. Case. Rep. 2021;15:1–5.
Copyright (c) 2024 Imelda Menchaca-Armenta, Flor L. Norato Canales, Eduardo Bustos Vázquez, Gisela Galindo Juárez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.